Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome
Gloria Peiró(Hospital General Universitario de Alicante Doctor Balmis), Joachim Diebold(University of Lucerne)
Cited by 60
Related Papers
Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
|British Journal of Cancer|2014|94
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors
|Science Translational Medicine|2017|64